Early congenital syphilis, latent form

Early Congenital Syphilis, Latent Form (ICD-11: 1A60.1) 1. Introduction Early congenital syphilis, latent form, represents a specific presentation of infection by Trepo

Compartir

Early Congenital Syphilis, Latent Form (ICD-11: 1A60.1)

1. Introduction

Early congenital syphilis, latent form, represents a specific presentation of Treponema pallidum infection transmitted vertically from the pregnant woman to the fetus. This clinical form is characterized by the absence of evident symptomatic manifestations, despite confirmed presence of infection through positive serological tests in children under two years of age.

The clinical importance of this condition lies in the diagnostic challenge it represents and in the risk of progression to severe symptomatic forms if not treated adequately. Unlike symptomatic early congenital syphilis, where clinical manifestations are evident at birth or in the first months of life, the latent form may go unnoticed without adequate laboratory screening, perpetuating the chain of transmission and allowing progressive damage to the organs and systems of the newborn.

From an epidemiological standpoint, congenital syphilis remains a significant global public health problem, with concerning resurgence in recent decades. The early latent form represents a considerable proportion of diagnosed cases, especially in contexts where there is effective prenatal screening but inadequate follow-up or delayed maternal treatment.

Correct coding of this condition is critical for multiple reasons: it enables precise epidemiological tracking, facilitates resource planning for treatment and follow-up, ensures adequate reimbursement for services provided, and fundamentally ensures that these children receive appropriate longitudinal monitoring to detect possible late complications. The clear distinction between symptomatic and latent forms of early congenital syphilis has direct implications for clinical management and prognosis.

2. Correct ICD-11 Code

Code: 1A60.1

Description: Early congenital syphilis, latent form

Parent category: 1A60 - Congenital syphilis

This specific ICD-11 code identifies cases of congenital syphilis diagnosed in children under two years of age who present serological evidence of Treponema pallidum infection, but who do not manifest signs or symptoms of the disease at the time of evaluation.

The classification as "early" refers to the temporal period of manifestation or diagnosis, conventionally established as the first two years of life. This temporal landmark is clinically relevant because the manifestations of congenital syphilis differ significantly between early and late phases, both in clinical presentation and in affected target organs.

The term "latent" specifically indicates the absence of detectable clinical manifestations on physical examination, despite laboratory confirmation of infection. This distinction is fundamental to differentiate from 1A60.0 (symptomatic form), where there is clear clinical evidence of disease.

The hierarchical structure of ICD-11 positions this code within the broader category of congenital syphilis (1A60), which in turn is inserted in the chapter of infectious diseases. This organization facilitates navigation and understanding of the relationships between different presentations of the same underlying condition.

3. When to Use This Code

Scenario 1: Newborn of mother with inadequately treated syphilis

A child born to a pregnant woman with a diagnosis of syphilis during prenatal care, but who received inadequate treatment (incomplete regimen, inadequate medication, or treatment initiated less than 30 days before delivery). The newborn presents with positive treponemal tests, reactive VDRL/RPR titers, but completely normal physical examination, without hepatosplenomegaly, skin lesions, radiological bone alterations, or other clinical manifestations. Cerebrospinal fluid evaluation does not demonstrate alterations. This is the classic scenario for application of code 1A60.1.

Scenario 2: Infant identified on late screening

A six-month-old child without documented prenatal follow-up of the mother, submitted to serological screening during routine evaluation or for another reason. Treponemal tests return positive, with reactive non-treponemal test titers. On detailed physical examination, there are no clinical signs of congenital syphilis. Bone radiographs do not demonstrate characteristic alterations. Ophthalmological examination and hearing evaluation are normal. Despite the absence of symptoms, serological confirmation in a child younger than two years justifies code 1A60.1.

Scenario 3: Newborn with persistently positive serology

A baby born to a mother adequately treated for syphilis, but who at three months of age maintains stable or elevated VDRL/RPR titers, when progressive decline of passively transferred maternal antibodies would be expected. The child remains asymptomatic on physical examination, without organomegaly, mucocutaneous lesions, or alterations in complementary tests. The persistence or elevation of titers in an asymptomatic child constitutes early latent congenital syphilis.

Scenario 4: Diagnosis during investigation of maternal exposure

A 15-month-old child whose mother was diagnosed with secondary syphilis after delivery. Retrospective investigation reveals that the pregnant woman had undiagnosed infection during pregnancy. The child, although having developed normally to date, presents with positive serology for syphilis with significant non-treponemal test titers. Complete clinical evaluation, including neurological, ophthalmological, and radiological examinations, does not identify abnormalities. This scenario of retrospective diagnosis in an asymptomatic child younger than two years corresponds to code 1A60.1.

Scenario 5: Follow-up of case with documented seroconversion

An infant initially with negative serology at birth, but who on reevaluation at two months presents seroconversion with positive treponemal tests and increasing VDRL/RPR titers. Maternal investigation reveals that the mother developed syphilis in the immediate postpartum period, suggesting possible peripartum transmission or late maternal infection during pregnancy with immunological window. The child remains without detectable clinical manifestations. This pattern of seroconversion in an asymptomatic infant justifies the use of code 1A60.1.

Scenario 6: Child on prophylactic treatment

A newborn submitted to prophylactic treatment for congenital syphilis due to inadequate maternal treatment, but who did not present clinical manifestations at birth. During post-treatment follow-up, maintains positive serology without clinical symptoms. While remaining asymptomatic and within the first two years of life, code 1A60.1 is appropriate to document the latent condition, even during and after treatment.

4. When NOT to Use This Code

Early congenital syphilis with clinical manifestations: When a child under two years of age presents with any sign or symptom attributable to congenital syphilis, such as cutaneous lesions (pemphigus palmoplantaris, flat condyloma), hepatosplenomegaly, jaundice, anemia, thrombocytopenia, osteochondritis, periostitis, serosanguineous rhinitis, or any other clinical manifestation, the correct code is 1A60.0 (Early congenital syphilis, symptomatic), not 1A60.1.

Late congenital syphilis: In children aged two years or older, even if asymptomatic at the time of evaluation, code 1A60.1 is not used. Late forms of congenital syphilis have specific coding (1A60.2 for ocular disease, 1A60.3 for late neurosyphilis, or other appropriate subcategories), regardless of the presence or absence of symptoms at the time of coding.

Exposure to syphilis without confirmed infection: Newborns of mothers with syphilis who received adequate treatment and who present only passively transferred maternal antibodies, with titers in progressive decline and that become negative as expected, should not receive code 1A60.1. These cases represent exposure without confirmed infection and should be coded appropriately as perinatal exposure or observation.

Acquired syphilis in children: Although rare, children may acquire syphilis through routes other than vertical transmission. Cases of acquired syphilis, even in young children, should be coded in the appropriate categories of acquired syphilis, not as congenital syphilis.

Serologic false-positive: Situations where there is reactivity in treponemal tests but with non-treponemal tests negative or very low titers, without confirmed maternal history and with complementary investigation ruling out true infection, do not justify code 1A60.1. These situations require coding as abnormal laboratory finding or diagnostic investigation.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

The diagnosis of early latent congenital syphilis requires definitive laboratory confirmation through serological testing. Initially, a treponemal test (FTA-Abs, TPHA, or immunoenzymatic/chemiluminescent tests) is performed, which should return positive. Complementarily, non-treponemal tests (VDRL or RPR) should demonstrate reactive titers.

The evaluation should include detailed maternal history, documenting diagnosis of syphilis during pregnancy, treatment received (medication, dose, duration, timing in relation to delivery), and serological response to treatment. Absence of known maternal history does not exclude the diagnosis if the child presents with positive serology.

Complete physical examination is mandatory to confirm the absence of clinical manifestations. Systematic evaluation should include: skin and mucous membranes (searching for bullous lesions, maculopapular rash, perioral fissures), abdominal palpation (hepatosplenomegaly), osteoarticular examination (pseudoparalysis, extremity edema), growth and developmental assessment, and neurological examination.

Complementary evaluations include: complete blood count (ruling out anemia, leukocytosis, thrombocytopenia), liver function, long bone radiographs (excluding osteochondritis and periostitis), lumbar puncture for cerebrospinal fluid analysis (cellularity, proteinorrachia, VDRL in cerebrospinal fluid), and ophthalmological and audiological examinations when available.

Step 2: Verify specifiers

The main temporal specifier is the child's age at the time of diagnosis, which must be less than two years for classification as "early." Documenting age precisely in months facilitates longitudinal follow-up and potential reclassification if late manifestations emerge after two years.

Characterization as "latent" requires explicit negative documentation: absence of clinical symptoms, normal physical examination, bone radiographs without characteristic alterations, and, ideally, normal cerebrospinal fluid. This negative documentation is as important as positive findings on serological tests.

Non-treponemal test titers should be documented quantitatively (example: VDRL 1:16), as they will serve as baseline for monitoring treatment response. Maternal titers, when available, should be recorded for comparison, since child titers higher than maternal titers by at least two dilutions suggest true infection versus passively transferred antibodies.

Step 3: Differentiate from other codes

1A60.0 - Early symptomatic congenital syphilis: The fundamental difference lies in the presence of clinical manifestations. If there is any sign or symptom attributable to syphilis (cutaneous lesions, hepatosplenomegaly, hematological alterations, radiological osteochondritis, neurosyphilis), use 1A60.0. The latent form (1A60.1) is specifically characterized by the complete absence of clinical manifestations despite serological confirmation.

1A60.2 - Late congenital syphilitic ocular disease: This code applies to ophthalmological manifestations of congenital syphilis that emerge after two years of age, such as interstitial keratitis, chorioretinitis, or other ocular complications. The temporal differentiation (less than versus greater than two years) and the presence of specific ocular involvement clearly distinguish it from 1A60.1.

1A60.3 - Late congenital neurosyphilis: Refers to central nervous system involvement manifesting after two years of age, including juvenile general paresis, juvenile tabes dorsalis, or other late neurological manifestations. It differs from 1A60.1 both by temporal criteria and by the presence of specific neurological manifestations.

Step 4: Required documentation

Checklist of mandatory information:

  • Precise age of the child in months at the time of diagnosis
  • Results of treponemal tests (type of test, qualitative result)
  • Results of non-treponemal tests (VDRL or RPR with quantitative titer)
  • Maternal history of syphilis (diagnosis, treatment, serological response)
  • Detailed description of physical examination documenting absence of clinical manifestations
  • Results of long bone radiographs
  • Results of cerebrospinal fluid analysis (when performed)
  • Results of complete blood count and liver function
  • Ophthalmological and audiological evaluations (when performed)

Adequate documentation should include:

Clear narrative establishing the diagnosis: "Infant of [X] months, child of mother with syphilis [treated/untreated/inadequately treated] during pregnancy. Presents with positive treponemal tests and reactive VDRL at titer of [X]. Physical examination without alterations. Normal bone radiographs. Cerebrospinal fluid without alterations. Consistent with early congenital syphilis, latent form."

Justification for classification as latent: explicit documentation of the absence of clinical signs and symptoms, with description of which organs and systems were evaluated and found to be normal.

6. Complete Practical Example

Clinical Case

A four-month-old male infant is brought for a child health consultation at a primary health care unit. The mother, 24 years old, reports having had irregular prenatal care with late initiation in the third trimester. Review of available records reveals that the pregnant woman had positive syphilis serology at the first prenatal visit (28 weeks of gestation), with VDRL of 1:64.

The mother received one dose of benzathine penicillin 2,400,000 IU two weeks before delivery, therefore treatment considered inadequate (less than 30 days before delivery). There is no documentation of partner treatment. Delivery was vaginal at term, without complications, and the newborn had good vitality at birth.

At the maternity ward, tests were collected from the newborn: VDRL 1:64 (same maternal titer) and FTA-Abs IgM not performed due to unavailability. The baby was discharged from the hospital at 48 hours of life with guidance for outpatient follow-up, but the family did not attend the scheduled appointments.

At four months, at the current consultation, the child is active, reactive, with neuropsychomotor development appropriate for age. Weight and height at the 50th percentile for age. On physical examination: skin and mucous membranes without lesions, absence of hepatosplenomegaly, no lymphadenopathy, osteoarticular examination without alterations, no signs of pseudoparalysis or extremity edema.

New tests are requested: VDRL returns 1:32 (decrease of one dilution compared to birth), FTA-Abs positive, normal complete blood count, normal liver function. Long bone radiographs show no alterations suggestive of osteochondritis or periostitis. Lumbar puncture performed: cerebrospinal fluid with normal cellularity, normal proteins, VDRL in cerebrospinal fluid non-reactive.

Step-by-Step Coding

Criteria analysis:

  1. Age: Four months - criterion of "early" satisfied (less than two years)
  2. Serological confirmation: FTA-Abs positive and VDRL reactive at significant titer - infection confirmed
  3. Maternal history: Maternal syphilis inadequately treated - high risk of vertical transmission
  4. Absence of clinical manifestations: Completely normal physical examination, no signs of active disease
  5. Complementary evaluations: Normal radiographs, normal cerebrospinal fluid, normal complete blood count - excluding symptomatic forms

Code chosen: 1A60.1 - Early congenital syphilis, latent form

Complete justification:

The infant meets all criteria for congenital syphilis: born to a mother with inadequately treated syphilis, presents serological confirmation with positive treponemal test and reactive non-treponemal test at titers that cannot be attributed solely to passively transferred maternal antibodies (maintains elevated titer at four months when significant decline should already be occurring).

The classification as "early" is appropriate due to the age of four months, well below the two-year limit. The characterization as "latent" is justified by the complete absence of clinical manifestations on detailed physical examination and by the normality of all complementary evaluations performed (bone radiographs, cerebrospinal fluid analysis, complete blood count).

It differs from 1A60.0 (symptomatic form) by the absence of clinical signs. No code for late congenital syphilis applies since the child is only four months old.

Complementary codes:

  • Z20.2 (Contact with and exposure to infections with predominantly sexual mode of transmission) - may be used additionally to document maternal exposure
  • Codes for procedures performed (lumbar puncture, radiographs) according to the procedure coding system used

Treatment plan and follow-up:

The child should receive treatment with crystalline or procaine penicillin according to established protocols for congenital syphilis. Follow-up will include periodic serological reevaluations (monthly until negativation, then quarterly until one year), monitoring of neuropsychomotor development, ophthalmological and audiological evaluations. The coding 1A60.1 remains valid during treatment and follow-up as long as the child remains asymptomatic and within the first two years of life.

7. Related Codes and Differentiation

Within the Same Category

1A60.0 - Early symptomatic congenital syphilis

When to use: This code is used when a child under two years of age presents with evident clinical manifestations of congenital syphilis. These may include cutaneous lesions (pemphigus palmoplantaris, maculopapular eruptions, condyloma latum), hepatosplenomegaly, jaundice, serosanguineous rhinitis ("syphilitic coryza"), generalized lymphadenopathy, hematological alterations (hemolytic anemia, leukocytosis, thrombocytopenia), bone manifestations (osteochondritis, periostitis, Parrot's pseudoparalysis), or symptomatic neurosyphilis.

Main difference: The presence of any clinical manifestation detectable on physical examination or through complementary tests (radiographs with bone alterations, cerebrospinal fluid with findings suggestive of neurosyphilis) characterizes the symptomatic form (1A60.0). In contrast, 1A60.1 requires complete absence of signs and symptoms, despite serological confirmation. The distinction is purely clinical, not serological—laboratory tests may be identical in both forms.

1A60.2 - Late congenital syphilitic oculopathy

When to use: This code is applicable when there are specific ophthalmological manifestations of congenital syphilis that develop after two years of age. The main manifestations include interstitial keratitis (usually between 5-20 years), chorioretinitis, optic atrophy, and other ocular complications. Even if diagnosed late in adolescents or young adults, these complications are coded as late if the infection was congenital.

Main difference: Two criteria clearly distinguish this from 1A60.1: first, the temporal criterion (manifestation after two years versus diagnosis before two years); second, the presence of specific ocular involvement. A child with 1A60.1 who develops interstitial keratitis at five years of age would have their coding updated to 1A60.2, reflecting progression to symptomatic late form.

1A60.3 - Late congenital neurosyphilis

When to use: Applies to neurological manifestations of congenital syphilis that arise after two years of age, including juvenile general paresis (progressive mental deterioration, usually between 10-20 years), juvenile tabes dorsalis (ataxia, hypotonia, areflexia), late sensorineural hearing loss, hydrocephalus, and other late neurological complications. Diagnosis requires clinical evidence of neurological involvement and, ideally, alterations in cerebrospinal fluid.

Main difference: Distinguished from 1A60.1 by the temporal criterion (manifestation after two years) and by the presence of specific neurological involvement. It is important to note that a child with altered cerebrospinal fluid before two years of age but without clinical manifestations would still be coded as 1A60.1 if remaining asymptomatic, but with indication for more aggressive treatment. Code 1A60.3 is reserved for clinically evident neurological manifestations after two years of age.

Differential Diagnoses

Other congenital infections of the TORCH complex: Toxoplasmosis, rubella, cytomegalovirus, and herpes simplex may present with clinical manifestations similar to symptomatic congenital syphilis (hepatosplenomegaly, jaundice, cutaneous lesions, neurological alterations). Differentiation is based on specific serological tests for each agent. In the latent form of congenital syphilis, the absence of symptoms facilitates distinction, but serological screening for other congenital infections may be necessary in cases of diagnostic doubt.

False-positive reaction in treponemal tests: Although rare, reactivity in treponemal tests can occur without true infection, especially in the presence of autoimmune diseases, other chronic infections, or conditions causing hypergammaglobulinemia. Distinction requires careful evaluation of the clinical context, detailed maternal history, and pattern of complementary tests. Negative non-treponemal tests or those with very low titers, in the absence of confirmed maternal history, suggest false-positive.

8. Differences with ICD-10

In ICD-10, the equivalent code for early latent congenital syphilis is A50.1. The structure of ICD-10 groups the manifestations of congenital syphilis in a similar manner, but with some important organizational differences.

The main change in the transition to ICD-11 is the more detailed alphanumeric structure, with code 1A60.1 offering greater specificity in the hierarchy of categories. ICD-11 uses the prefix "1A" for infectious diseases, followed by specific subcategories, whereas ICD-10 uses chapter "A" with sequential numbering.

Another significant difference is the greater clarity in ICD-11 regarding the temporal criteria for classification between early and late forms. Although both classifications use the two-year milestone, ICD-11 provides more detailed descriptions and clearer guidance for code application.

ICD-11 also offers better integration with electronic medical record systems, with data structure more suitable for digital coding and interoperability between different health systems. This facilitates epidemiological tracking and large-scale data analysis.

From a practical standpoint, professionals familiar with ICD-10 code A50.1 should recognize that 1A60.1 represents essentially the same clinical condition, with the transition being primarily administrative and structural. The clinical and laboratory diagnostic criteria remain unchanged, as do the therapeutic and follow-up approaches.

9. Frequently Asked Questions

How is early latent congenital syphilis diagnosed?

The diagnosis requires a combination of criteria: serological confirmation with positive treponemal tests (FTA-Abs, TPHA, or immunoenzymatic tests) and reactive non-treponemal tests (VDRL or RPR) at significant titers, associated with complete absence of clinical manifestations on detailed physical examination. Maternal history of syphilis during pregnancy, especially if inadequately treated, strengthens the diagnosis. Complementary evaluations (bone radiographs, cerebrospinal fluid analysis, complete blood count) should be normal to characterize the latent form. The child's age must be less than two years at the time of diagnosis.

Is treatment available in public health systems?

Yes, treatment for congenital syphilis is generally available in public health systems in various countries, as penicillin, the drug of choice, is relatively accessible and is included in essential medication lists of international health organizations. Treatment of congenital syphilis is considered a priority in maternal and child health programs due to its significant impact on child morbidity and mortality and the effectiveness of treatment when instituted early.

How long does treatment last?

The duration of treatment depends on the regimen used. For early latent congenital syphilis without neurological involvement, typical treatment with intravenous crystalline penicillin lasts 10 days. Alternatively, intramuscular procaine penicillin can be used daily for 10 days. In cases with cerebrospinal fluid alterations suggestive of neurosyphilis, even without clinical manifestations, some protocols recommend extending treatment. Post-treatment follow-up extends for months to years, with periodic serological reevaluations to confirm adequate response.

Can this code be used in medical certificates?

Yes, code 1A60.1 can be used in official medical documentation, including certificates when necessary. However, it is important to consider confidentiality and stigma aspects associated with the diagnosis of sexually transmitted infections. In some contexts, it may be appropriate to use more generic terminology in documents that will be widely shared, reserving specific coding for protected medical records. The decision should balance the need for diagnostic precision with protection of patient and family privacy.

Can a child treated for early latent congenital syphilis develop late manifestations?

Although adequate treatment of congenital syphilis is highly effective in preventing complications, there is residual risk of development of late manifestations, especially if treatment was inadequate or incomplete. Therefore, longitudinal follow-up is essential, including periodic ophthalmological, auditory, and neuropsychomotor development evaluations. Children treated for congenital syphilis should be followed until adolescence for early detection of possible late complications such as interstitial keratitis or hearing alterations.

How to differentiate passively transferred maternal antibodies from true infection?

This is a frequent diagnostic question. Maternal IgG antibodies are passively transferred through the placenta and can persist for up to 12-15 months. The distinction is based on: child's non-treponemal test titers (VDRL/RPR) superior to maternal titers by at least two dilutions suggesting true infection; persistence or elevation of titers beyond 3-4 months when they should be declining; testing for specific IgM (when available and reliable); and presence of any clinical manifestation. In case of doubt, it is preferable to treat presumptively as true infection given the risk of complications if untreated.

What is the importance of treating the mother's sexual partner?

Partner treatment is fundamental to prevent maternal reinfection and vertical transmission in future pregnancies. Untreated partners can reinfect the treated mother, perpetuating the cycle of transmission. Furthermore, inadequate partner treatment is one of the criteria that characterizes maternal treatment as inadequate, even if the pregnant woman received the correct therapeutic regimen. Effective congenital syphilis control programs include strategies to ensure concomitant treatment of sexual partners.

Do children with early latent congenital syphilis need isolation or special precautions?

No. Early latent congenital syphilis, by definition, does not present with active lesions or infectious secretions. Children with this condition do not require isolation and can attend daycare, schools, and community settings normally. Standard hygiene precautions are sufficient. Unlike the symptomatic form with active mucocutaneous lesions (which may be infectious), the latent form does not represent a risk of horizontal transmission. The stigma associated with the diagnosis should be combated through appropriate education of family members and health professionals.


Final note: This article provides general guidance on coding early latent congenital syphilis according to ICD-11. Clinical and coding decisions should always consider the specific context of each case, local institutional protocols, and current national or international guidelines. In situations of diagnostic or coding doubt, consultation with specialists in pediatric infectology, perinatology, or medical coding is recommended.

External References

This article was prepared based on reliable scientific sources:

  1. 🌍 WHO ICD-11 - Early congenital syphilis, latent form
  2. 🔬 PubMed Research on Early congenital syphilis, latent form
  3. 🌍 WHO Health Topics
  4. 📋 CDC - Centers for Disease Control
  5. 📊 Clinical Evidence: Early congenital syphilis, latent form
  6. 📋 Ministry of Health - Brazil
  7. 📊 Cochrane Systematic Reviews

References verified on 2026-02-04

Códigos Relacionados

Cómo Citar Este Artículo

Formato Vancouver

Administrador CID-11. Early congenital syphilis, latent form. IndexICD [Internet]. 2026-02-04 [citado 2026-03-29]. Disponível em:

Use esta cita en trabajos académicos, TCC, monografías y artículos científicos.

Compartir